Gene construction,protein purification and activity evaluation of scFv anti-CD5
Jianghua Yan
Abstract
Jianghua Yan
Abstract
Purpose To construct a genetic engineering E.coli strain with high expression level of scFv anti-CD5 and to lay the foundation for tumor immunotherapy using scFv anti-CD5 as a component.Methods VH and VL fragment of H65(an anti-CD5 mAb)is acquired from Genbank,and then joined with a linker coding sequence,and the gene via overlapping PCR is constructed.The gene is digested and inserted into pET22b(+) to form a recombinant plasmid.The E.coli BL21(DE3) bear the plasmid with right sequence is induced with IPTG and the product is purified with Ni-NTA column,renatured,and subjected to activity analysis via FCM and Western blotting.Results The recombinant plasmid and the engineering E.coli strain with high expression level of scFv anti-CD5 were acquired.The expression products were able to recognize CD5 antigen after being renatured.Conclusion The acquisition of engineering E.coli strain with high expression level of scFv anti-CD5 would contribute to further application of scFv anti-CD5.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Purpose To construct a genetic engineering E.coli strain with high expression level of scFv anti-CD5 and to lay the foundation for tumor immunotherapy using scFv anti-CD5 as a component.Methods VH and VL fragment of H65(an anti-CD5 mAb)is acquired from Genbank,and then joined with a linker coding sequence,and the gene via overlapping PCR is constructed.The gene is digested and inserted into pET22b(+) to form a recombinant plasmid.The E.coli BL21(DE3) bear the plasmid with right sequence is induced with IPTG and the product is purified with Ni-NTA column,renatured,and subjected to activity analysis via FCM and Western blotting.Results The recombinant plasmid and the engineering E.coli strain with high expression level of scFv anti-CD5 were acquired.The expression products were able to recognize CD5 antigen after being renatured.Conclusion The acquisition of engineering E.coli strain with high expression level of scFv anti-CD5 would contribute to further application of scFv anti-CD5.
Key concepts: Molecular biology, Recombinant DNA, Escherichia coli, Plasmid, Gene, CD5, Biology, Blot